mtDNA depletion confers specific gene expression profiles in human cells grown in culture and in xenograft
Authors:
- Darren MagdaDMDarren Magda
- Philip LecanePLPhilip Lecane
- Julia PrescottJPJulia Prescott
- Patricia ThiemannPTPatricia Thiemann
- Xuan MaXMXuan Ma
- Patricia K DranchakPDPatricia K Dranchak
- Donna M TolenoDTDonna M Toleno
- Krishna RamaswamyKRKrishna Ramaswamy
- Kimberly D SiegmundKSKimberly D Siegmund
- Joseph G HaciaJHJoseph G Hacia
Open Access
- 3 November 2008
- journal article
- research article
- Published by Springer Nature in BMC Genomics
- Vol. 9 (1) , 521
Abstract
Background: Interactions between the gene products encoded by the mitochondrial and nuclear genomes play critical roles in eukaryotic cellular function. However, the effects mitochondrial DNA (mtDNA) levels have on the nuclear transcriptome have not been defined under physiological conditions. In order to address this issue, we characterized the gene expression profiles of A549 lung cancer cells and their mtDNA-depleted ρ0 counterparts grown in culture and as tumor xenografts in immune-deficient mice. Results: Cultured A549 ρ0 cells were respiration-deficient and showed enhanced levels of transcripts relevant to metal homeostasis, initiation of the epithelial-mesenchymal transition, and glucuronidation pathways. Several well-established HIF-regulated transcripts showed increased or decreased abundance relative to the parental cell line. Furthermore, growth in culture versus xenograft has a significantly greater influence on expression profiles, including transcripts involved in mitochondrial structure and both aerobic and anaerobic energy metabolism. However, both in vitro and in vivo, mtDNA levels explained the majority of the variance observed in the expression of transcripts in glucuronidation, tRNA synthetase, and immune surveillance related pathways. mtDNA levels in A549 xenografts also affected the expression of genes, such as AMACR and PHYH, involved in peroxisomal lipid metabolic pathways. Conclusion: We have identified mtDNA-dependent gene expression profiles that are shared in cultured cells and in xenografts. These profiles indicate that mtDNA-depleted cells could provide informative model systems for the testing the efficacy of select classes of therapeutics, such as anti-angiogenesis agents. Furthermore, mtDNA-depleted cells grown culture and in xenografts provide a powerful means to investigate possible relationships between mitochondrial activity and gene expression profiles in normal and pathological cells.Keywords
This publication has 76 references indexed in Scilit:
- Transmitochondrial Technology in Animal Cells2007
- Building the power house: recent advances in mitochondrial studies through proteomics and systems biologyAmerican Journal of Physiology-Cell Physiology, 2007
- Mitochondria Damage Checkpoint, Aging, and CancerAnnals of the New York Academy of Sciences, 2006
- MitoP2: the mitochondrial proteome database--now including mouse dataNucleic Acids Research, 2006
- Mitochondrial gene‐knockout (ρ0) cells: A versatile model for exploring the secrets of trans‐plasma membrane electron transportBioFactors, 2004
- mtCLIC is up‐regulated and maintains a mitochondrial membrane potential in mtDNA‐depleted L929 cellsThe FASEB Journal, 2003
- Mitochondrial DNA depletion causes morphological changes in the mitochondrial reticulum of cultured human cellsFEBS Letters, 2000
- Cells depleted of mitochondrial DNA (p0) yield insight into physiological mechanismsFEBS Letters, 1999
- [27] Isolation of human cell lines lacking mitochondrial DNA1996
- Human Cells Lacking mtDNA: Repopulation with Exogenous Mitochondria by ComplementationScience, 1989